openPR Logo

Press Releases from DelveInsight Business Research LLP (4751 total)

Pericarditis Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapi …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, several major pharma and biotech companies are working on various pipeline therapies in the

Metastatic Prostate Cancer Pipeline Analysis (2023) Covering Clinical Trials, Em …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 90+ key pharma and biotech companies are working on 110+ pipeline drugs in

Cellular-mesenchymal Epithelial Transition Factor (C-Met) Mutated Non-Small Cell …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 5+ key pharma and biotech companies are working on 5+ pipeline drugs in

HPV+ Recurrent/Metastatic Head and Neck Cancer Pipeline Analysis (2023) Covering …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 5+ key pharma and biotech companies are working on 5+ pipeline drugs in

Skin Burns Pipeline | Clinical Trials During the Study Period (2019-2032)| Key C …

"Skin Burns Pipeline Insights, 2023" report by DelveInsight outlays comprehensive insights into the present clinical development scenario and growth prospects across the Skin Burns market.

Metastatic Pancreatic Cancer Pipeline | Clinical Trials Study Period (2019-2032) …

DelveInsight's "Metastatic Pancreatic Cancer - Market Insights, Epidemiology and Market Forecast- 2032" report delivers an in-depth understanding of the Metastatic Pancreatic Cancer, historical and forecasted

Hemophilia A Pipeline | Clinical Trials Study Period (2019-2032)| Key Companies …

DelveInsight's, "Hemophilia A -Pipeline Insights, 2023," report provides comprehensive insights about 40+ companies and 40+ pipeline drugs in the Hemophilia A pipeline landscape. It covers

Gastric Cancer Pipeline Insights Report 2023 (Updated)

(Albany, United States) As per DelveInsight's assessment, globally, the Gastric Cancer Pipeline constitutes 230+ key companies continuously working towards developing 230+ Gastric Cancer Pipeline treatment

Pulmonary Arterial Hypertension Pipeline Insights Report 2023 (Updated)

(Albany, United States) As per DelveInsight's assessment, globally, the Pulmonary Arterial Hypertension pipeline constitutes 55+ key companies continuously working towards developing 55+ Pulmonary Arterial Hypertension

Complement 3 Glomerulopathy Pipeline, Clinical Trials Assessment, NDA Approvals …

(Albany) DelveInsight's "Complement 3 Glomerulopathy Pipeline Insight 2023" report offers extensive knowledge on more than 3+ companies and 3+ pipeline drugs within the landscape of

Major Depressive Disorder Pipeline Insights Report 2023 (Updated)

DelveInsight's, "Major Depressive Disorder Pipeline Insight 2023" report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in the Major Depressive Disorder pipeline landscape.

Tay-Sachs Disease Pipeline, Clinical Trials Assessment, NDA Approvals 2023 (Upda …

(Albany, United States) As per DelveInsight's assessment, globally, the Tay-Sachs Disease pipeline constitutes 5+ key companies continuously working towards developing 5+ Tay-Sachs Disease treatment therapies,

Anaphylaxis Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapie …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 8+ key pharma and biotech companies are working on 8+ pipeline drugs in

High-Grade Glioma Pipeline Analysis (2023) Covering Clinical Trials, Emerging Th …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 150+ key pharma and biotech companies are working on 150+ pipeline drugs in

Metastatic Uveal Melanoma Pipeline Analysis (2023) Covering Clinical Trials, Eme …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 15+ key pharma and biotech companies are working on 15+ pipeline drugs in

Glaucoma Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, …

As per DelveInsight's assessment, globally, about 50+ key pharma and biotech companies are working on 50+ pipeline drugs in the Glaucoma therapeutics landscape based on

Desmoid Tumors Pipeline Analysis (2023) Covering Clinical Trials, Emerging Thera …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 12+ key pharma and biotech companies are working on 12+ pipeline drugs in

Mismatch Repair Deficiency Market to Witness Growth by 2032, Estimates DelveInsi …

DelveInsight's "Mismatch Repair Deficiency Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Mismatch Repair Deficiency, historical and forecasted epidemiology as well

Meningitis Market to Witness Growth by 2032, Estimates DelveInsight

DelveInsight's "Meningitis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Meningitis, historical and forecasted epidemiology as well as the Meningitis market

Complex Regional Pain Syndrome Market to Witness Growth by 2032, Estimates Delve …

DelveInsight's "Complex Regional Pain Syndrome Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Complex Regional Pain Syndrome, historical and forecasted epidemiology

Lymphocytopenia Market to Witness Growth by 2032, Estimates DelveInsight

DelveInsight's "Lymphocytopenia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Lymphocytopenia, historical and forecasted epidemiology as well as the Lymphocytopenia market

Oncolytic Virus Cancer Therapy Market to Witness Growth by 2032, Estimates Delve …

DelveInsight's "Oncolytic Virus Cancer Therapy Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Oncolytic Virus Cancer Therapy, historical and forecasted epidemiology

Nasopharyngeal Cancer Pipeline Analysis (2023) Covering Clinical Trials, Emergin …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 30+ key pharma and biotech companies are working on 30+ pipeline drugs in

Moderate To Severe Plaque Psoriasis Pipeline Analysis (2023) Covering Clinical T …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 30+ key pharma and biotech companies are working on 30+ pipeline drugs in

Oral Mucositis Pipeline Analysis (2023) Covering Clinical Trials, Emerging Thera …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 10+ key pharma and biotech companies are working on 10+ pipeline drugs in

Tenosynovial Giant Cell Tumors (TSGCTs) Pipeline Analysis Covering Clinical Tria …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 5+ key pharma and biotech companies are working on 5+ pipeline drugs in

Polymyalgia Rheumatica Pipeline Analysis (2023) Covering Clinical Trials, Emergi …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 5+ key pharma and biotech companies are working on 5+ pipeline drugs in

Graft versus host disease Pipeline, Clinical Trials Assessment, and FDA Approval …

DelveInsight's, "Graft versus host disease Pipeline Insight 2023" report provides comprehensive insights about 60+ Graft versus host disease companies and 65+ pipeline drugs in the

Relapsing Remitting Multiple Sclerosis Pipeline, Clinical Trials Assessment, and …

DelveInsight's, "Relapsing Remitting Multiple Sclerosis Pipeline Insight 2023" report provides comprehensive insights about 25+ companies and 28+ pipeline drugs in the Relapsing-Remitting Multiple Sclerosis pipeline

Attention Deficit Hyperactivity Disorder Pipeline, Clinical Trials Assessment, a …

DelveInsight's, "Attention Deficit Hyperactivity Disorder Pipeline Insight 2023" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in the Attention Deficit Hyperactivity Disorder

Epidermolysis Bullosa Pipeline, Clinical Trials Assessment, and FDA Approvals 20 …

DelveInsight's, "Epidermolysis Bullosa Pipeline Insight 2023" report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in the Epidermolysis Bullosa pipeline landscape. It covers

Myotonic Dystrophy Pipeline, Clinical Trials Assessment, and FDA Approvals 2023 …

DelveInsight's, "Myotonic Dystrophy Pipeline Insight, 2023," report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in the Myotonic Dystrophy pipeline landscape. It covers

Systemic Lupus Erythematosus Pipeline, Clinical and Non-Clinical Stage Products, …

DelveInsight's, "Systemic Lupus Erythematosus Pipeline Insight, 2023," report provides comprehensive insights about 55+ companies and 60+ pipeline drugs in the Systemic Lupus Erythematosus pipeline landscape.

Autistic Disorder Pipeline, Clinical and Non-Clinical Stage Products and FDA App …

DelveInsight's, "Autistic Disorder Pipeline Insight 2023" report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in Autistic Disorder pipeline landscape. It covers the

Hereditary Angioedema Pipeline, Clinical and Non-Clinical Products and FDA Appro …

DelveInsight's, "Hereditary Angioedema Pipeline Insight 2023" report provides comprehensive insights about 20+ companies and 30+ pipeline drugs in the Hereditary Angioedema pipeline landscape. It covers

Fabry Disease Pipeline, Clinical and Non-Clinical Stage Products, and FDA Approv …

DelveInsight's, "Fabry Disease Pipeline Insight 2023" report provides comprehensive insights about 18+ companies and 18+ pipeline drugs in the Fabry Disease pipeline landscape. It covers

Chronic Post-Amputation Pain Market to Witness a Robust Growth in the Upcoming Y …

DelveInsight's "Chronic Post-Amputation Pain Market Insight & Forecast" report will offer an in-depth understanding of the Chronic Post-Amputation Pain market, further benefiting the competitors or

Ornithine Transcarbamylase (OTC) Deficiency Market to Witness Growth by 2032, Es …

DelveInsight's "Ornithine Transcarbamylase (OTC) Deficiency Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Ornithine Transcarbamylase (OTC) Deficiency, historical and forecasted epidemiology

Fatty Acid Oxidation Disorders (FAODs) Market to Witness Growth by 2032, Estimat …

DelveInsight's "Fatty Acid Oxidation Disorders (FAODs) Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Fatty Acid Oxidation Disorders (FAODs), historical and

Intraocular Lymphoma Market to Witness Growth by 2032, Estimates DelveInsight | …

DelveInsight's "Intraocular Lymphoma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Intraocular Lymphoma, historical and forecasted epidemiology as well as the

Onycholysis Market to Witness Growth by 2032, Estimates DelveInsight | Companies …

DelveInsight's "Onycholysis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Onycholysis, historical and forecasted epidemiology as well as the Onycholysis market

Chronic Hand Eczema Pipeline Analysis (2023) Covering Clinical Trials, Emerging …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 5+ key pharma and biotech companies are working on 5+ pipeline drugs in

Steroid Refractory Acute Graft Versus Host Disease Pipeline Analysis (2023) Cove …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 10+ key pharma and biotech companies are working on 10+ pipeline drugs in

Retinal Vein Occlusion Pipeline Analysis Covering Clinical Trials, Emerging Ther …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 15+ key pharma and biotech companies are working on 15+ pipeline drugs in

Duchenne Muscular Dystrophy Pipeline Analysis (2023) Covering Clinical Trials, E …

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 75+ key pharma and biotech companies are working on 75+ pipeline drugs in

Non-alcoholic Steatohepatitis (NASH) Pipeline Analysis (2023) Covering Clinical …

Non-alcoholic Steatohepatitis (NASH) Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | ML Bio Solutions, Asklepios, Sarepta, Atamyo,

Severe Asthma Pipeline, Clinical Trials Key Companies - Teva Pharma, AstraZeneca …

DelveInsight's 'Severe Asthma Pipeline Insight, 2023" report by DelveInsight outlays comprehensive insights into the present clinical development scenario and growth prospects across the Severe Asthma

Multiple Myeloma Pipeline Clinical Trials, Growth, and Key Companies | Companies …

(Las Vegas Nevada United States), DelveInsight's, "Multiple Myeloma (MM) - Pipeline Insights, 2023," report provides comprehensive insights about 100+ companies and 130+ pipeline drugs in

Gastro-Intestinal Bleeding Clinical Trials | A Drug Pipeline Analysis Report 202 …

(Nevada, Las Vegas) United States, Gastro Intestinal Bleeding Pipeline Insight, 2023" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects

Gene Therapy For Ocular Rare Disease Pipeline, Clinical Trials | A Drug Pipeline …

Gene Therapy For Ocular Rare Disease Pipeline, Clinical Trials | A Drug Pipeline Analysis Report 2023 | Companies- Gamut Therapeutics (Nevada, Las Vegas) United States DelveInsight's

Go To Page:    71 72 73 74 75 76 77 78 79 80